Font Size:
a
A
A
Keyword [Chimeric antigen receptor T-cell]
Result: 21 - 40 | Page: 2 of 3
21.
The Efficacy And Safety Of Chimeric Antigen Receptor T Cells In The Treatment Of Relapsed/refractory B-cell Acute Lymphoblastic Leukemia
22.
Improved Radiotherapy Segmentation Combined With CAR-T Cell For B Cell Lymphoma
23.
Using The Flow Cytometry To Monitor And Screen The Quality Of The Starting T Cells Before CART Cell Preparation
24.
A Preclinical Study Of Anti-TSHR CAR-T Cell Therapy For Differentiated Thyroid Carcinoma
25.
Toxicities And Relative Factors Of CD19 Targeted Chimeric Antigen Receptor T Cell Therapy In Relapse/refractory B-cell Hematological Malignancies
26.
Hematologic Toxicity And Kinetics Of Immune Function And Relevant Factors Analysis After Chimeric Antigen Receptor T Cells Therapy In Relapsed/Refractory Acute B Lymphoblastic Leukemia
27.
A Case Report And Literature Review Of Follicular Lymphoma With TP53 Mutated Transformed Into Diffuse Large B Cell Lymphoma
28.
A Meta-analysis Of The Efficacy And Safety Of Chimeric Antigen Receptor-T Cells In The Treatment Of Relapsed/Refractory B-cell Lymphoma
29.
Anti-tumor Effects Of CD276-specific Chimeric Antigen Receptor T Cells In Esophageal Squamous Cell Carcinoma
30.
CD19/22 CAR T Cell Cocktail Therapy For B-ALL Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation
31.
Research On Dielectrophoresis Trapping-microwell Transfer Based Single Cell Sequencing Technology And Its Application In CAR-T Immunotherapy
32.
Primary Research Of Autologous Hematopoietic Stem Cell Transplantation With Chimeric Antigen Receptor Modified Hematopoietic Stem Cell For DLBCL
33.
The Investigation Of Enhanced Activity Of B7-H3 CAR T Cells Against Pancreatic And Breast Cancers By Pretreating Tumor Cells With The Combination Of DSF/Cu And IR
34.
The Clinical And Mechanistic Study Of Synergistic Combination Of IFN-α With CD19/CD22 Bispecific Targeted CAR-T Cell Therapy In Relapsed And Refractory Bcell Acute Lymphoblastic Leukemia
35.
Experimental Study Of γδT Cells And NKG2D Chimeric Antigen Receptor T Cells Immunotherapy Against Hepatocellular Carcinoma
36.
Extracellular Vesicles Armed With Target Antigen Or Cytokines Drive Efficacy Of Chimeric Antigen Receptor-T Cells
37.
The Mechanism Of T Cell Dysfunction Related Resistance In CAR T Therapy For Lymphoma
38.
KCNC1 Promotes The Progression Of Pancreatic Cancer By Reshaping Immune Microenvironment And Inhibiting CD8~+T Cell Function
39.
The Research Of CAR-T Cell Membrane-coated Photothermal-responsive Nanoparticles In Targeted Therapy For Hepatocellular Carcinoma
40.
Exploratory Study On The B7-H3 Chimeric Receptor T Cells For The Treatment Of Abdominal Implantation And Metastasis Of Colon Cancer
<<First
<Prev
Next>
Last>>
Jump to